Literature DB >> 522894

Propranolol in conscious spontaneously hypertensive rats. II. Disposition after subcutaneous and intracerebroventricular administration.

J M Smits, H A Struyker-Boudier.   

Abstract

The disposition of dl-propranolol was studied in spontaneously hypertensive rats (SHR), both after subcutaneous (s.c.) and intracerebroventricular (i.c.v.) injection of 1 mg/kg. 1. Upon s.c. injection propranolol appeared rapidly in plasma. A maximum concentration of 374 +/- 33 ng/ml (N = 10) was reached 5 min after injection. After a distribution phase with a half-life of t 1/2 alpha = 17 min propranolol was eliminated with a t 1/2 beta = 59 min. 2. Both propranolol and its metabolites were taken up rapidly into all tissues studied. Highest concentrations (10.4 +/- 1.5 micrograms/g, N = 5) were found in lungs 30 min after injection. 3. Neither propranolol nor its metabolites accumulated in any of the tissues examined. 4. Upon i.c.v. injection of propranolol, a maximal concentration of 573 +/- 47 ng/ml (N = 3) was reached in plasma already 2 min after injection. In this case t 1/2 alpha was 13 min and t 1/2 beta was 80 min. 5. Dialysis experiments indicated that propranolol is bound to plasma proteins for 92% in the concentration range of 20--100 ng/ml. With increasing concentrations binding diminishes progressively. At the highest concentration tested (345 ng/ml) only 76% was bound. It is concluded that s.c. and i.c.v. injection of an identical dose of propranolol gives a similar plasma concentration-time profile. Moreover, it is suggested that the pharmacokinetic behaviour of propranolol in SHR does not explain the delayed antihypertensive effect of this drug.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 522894     DOI: 10.1007/BF00498752

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  21 in total

1.  The osmotic minipump: a new tool in the study of steady-state kinetics of drug distribution and metabolism.

Authors:  H A Struyker-Boudier; J F Smits
Journal:  J Pharm Pharmacol       Date:  1978-09       Impact factor: 3.765

2.  Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension.

Authors:  L Hansson; A J Zweifler; S Julius; S N Hunyor
Journal:  Acta Med Scand       Date:  1974 Jul-Aug

3.  The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.

Authors:  G H Evans; A S Nies; D G Shand
Journal:  J Pharmacol Exp Ther       Date:  1973-07       Impact factor: 4.030

4.  Propranolol in conscious spontaneously hypertensive rats. I. Cardiovascular effects after subcutaneous and intracerebroventricular administration.

Authors:  J F Smits; H van Essen; H A Struyker-Boudier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-10       Impact factor: 3.000

Review 5.  Methods for obtaining drug time course data from individual small laboratory animals: serial microblood sampling and assay.

Authors:  B H Migdalof
Journal:  Drug Metab Rev       Date:  1976       Impact factor: 4.518

Review 6.  Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.

Authors:  D G Shand
Journal:  Drugs       Date:  1974       Impact factor: 9.546

Review 7.  Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure.

Authors:  K O Stumpe; R Kolloch; H Vetter; W Gramann; F Krück; C Ressel; M Higuchi
Journal:  Am J Med       Date:  1976-05-31       Impact factor: 4.965

8.  Studies on the pharmacokinetics and pharmacodynamics of atenolol in man.

Authors:  J D Fitzgerald; R Ruffin; K G Smedstad; R Roberts; J McAinsh
Journal:  Eur J Clin Pharmacol       Date:  1978-05-17       Impact factor: 2.953

9.  Steady-state disposition of propranolol and its total metabolites in the spontaneously hypertensive rat: chronic subcutaneous vs. intracerebroventricular infusion with osmotic minipumps.

Authors:  J F Smits; H A Struyker-Boudier
Journal:  J Pharmacol Exp Ther       Date:  1979-06       Impact factor: 4.030

10.  The role of the baroreceptor reflex in the cardiovascular effects of propranolol in the conscious spontaneously hypertensive rat.

Authors:  H A Struyker-Boudier; J F Smits; H Van Essen
Journal:  Clin Sci (Lond)       Date:  1979-02       Impact factor: 6.124

View more
  8 in total

1.  Propranolol in conscious spontaneously hypertensive rats. I. Cardiovascular effects after subcutaneous and intracerebroventricular administration.

Authors:  J F Smits; H van Essen; H A Struyker-Boudier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-10       Impact factor: 3.000

2.  Brain levels and acute antihypertensive activity of beta-blockers.

Authors:  P A van Zwieten; P B Timmermans
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  The pharmacokinetic properties of yohimbine in the conscious rat.

Authors:  J W Hubbard; S L Pfister; A M Biediger; T C Herzig; T K Keeton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-05       Impact factor: 3.000

4.  Changes in neurotransmitter sensitivity in the mouse neocortical slice following propranolol and theophylline administration.

Authors:  J Mally; J H Connick; T W Stone
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

5.  Avoidance of "first-pass" elimination of rectally administered propranolol in relation to the site of absorption in rats.

Authors:  L G de Leede; A G de Boer; J P Havermans; D D Breimer
Journal:  Pharm Res       Date:  1984-07       Impact factor: 4.200

6.  Ocular Versus Oral Propranolol for Prevention and/or Treatment of Oxygen-Induced Retinopathy in a Rat Model.

Authors:  Areej Qadri; Charles L Cai; Karen Deslouches; Faisal Siddiqui; Jacob V Aranda; Kay D Beharry
Journal:  J Ocul Pharmacol Ther       Date:  2021-02-03       Impact factor: 2.671

7.  β-adrenergic modulation of discrimination learning and memory in the auditory cortex.

Authors:  Horst Schicknick; Julia U Henschke; Eike Budinger; Frank W Ohl; Eckart D Gundelfinger; Wolfgang Tischmeyer
Journal:  Eur J Neurosci       Date:  2019-07-01       Impact factor: 3.386

8.  Locus Coeruleus Stimulation Facilitates Long-Term Depression in the Dentate Gyrus That Requires Activation of β-Adrenergic Receptors.

Authors:  Niels Hansen; Denise Manahan-Vaughan
Journal:  Cereb Cortex       Date:  2014-01-23       Impact factor: 5.357

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.